These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 9740353)

  • 1. Cytokines and therapeutic oligonucleotides.
    Hartmann G; Bidlingmaier M; Eigler A; Hacker U; Endres S
    Cytokines Cell Mol Ther; 1997 Dec; 3(4):247-56. PubMed ID: 9740353
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Not nonsense but antisense--applications of antisense oligonucleotides in different fields of medicine.
    Oberbauer R
    Wien Klin Wochenschr; 1997 Jan; 109(2):40-6. PubMed ID: 9123943
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antisense oligonucleotides as therapeutics for malignant diseases.
    Ho PT; Parkinson DR
    Semin Oncol; 1997 Apr; 24(2):187-202. PubMed ID: 9129689
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immune mechanisms and therapeutic potential of CpG oligodeoxynucleotides.
    Wilson HL; Dar A; Napper SK; Marianela Lopez A; Babiuk LA; Mutwiri GK
    Int Rev Immunol; 2006; 25(3-4):183-213. PubMed ID: 16818371
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of antisense oligodeoxynucleotides for transplantation.
    Stepkowski SM
    Curr Opin Mol Ther; 2000 Jun; 2(3):304-17. PubMed ID: 11249625
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Therapeutic oligonucleotides: the state-of-the-art in purification technologies.
    Sanghvi YS; Schulte M
    Curr Opin Drug Discov Devel; 2004 Nov; 7(6):765-76. PubMed ID: 15595437
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nucleic acid aptamers as tools and drugs: recent developments.
    Rimmele M
    Chembiochem; 2003 Oct; 4(10):963-71. PubMed ID: 14523912
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunomodulation by cytokine antisense oligonucleotides.
    Lefebvre d'Hellencourt C; Diaw L; Guenounou M
    Eur Cytokine Netw; 1995; 6(1):7-19. PubMed ID: 7795178
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Emerging oligonucleotide therapies for asthma and chronic obstructive pulmonary disease.
    Séguin RM; Ferrari N
    Expert Opin Investig Drugs; 2009 Oct; 18(10):1505-17. PubMed ID: 19715448
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antisense oligonucleotide therapy in urology.
    Kausch I; Böhle A
    J Urol; 2002 Jul; 168(1):239-47. PubMed ID: 12050550
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aptamers against extracellular targets for in vivo applications.
    Pestourie C; Tavitian B; Duconge F
    Biochimie; 2005; 87(9-10):921-30. PubMed ID: 15963620
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Basics of antisense oligonucleotide therapy and current therapeutical strategies in urology].
    Kausch I; Böhle A
    Aktuelle Urol; 2003 Dec; 34(7):458-68. PubMed ID: 14655082
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Locked vs. unlocked nucleic acids (LNA vs. UNA): contrasting structures work towards common therapeutic goals.
    Campbell MA; Wengel J
    Chem Soc Rev; 2011 Dec; 40(12):5680-9. PubMed ID: 21556437
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Delivery of intercellular adhesion molecule-1 antisense oligonucleotides using a topical hydrogel tissue sealant in a murine partial nephrectomy/ischemia model.
    Phull H; Lien YH; Salkini MW; Escobar C; Lai LW; Ramakumar S
    Urology; 2008 Sep; 72(3):690-5. PubMed ID: 18336877
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical application of CpG-, non-CpG-, and antisense oligodeoxynucleotides as immunomodulators.
    Dorn A; Kippenberger S
    Curr Opin Mol Ther; 2008 Feb; 10(1):10-20. PubMed ID: 18228177
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Allosteric aptamers: targeted reversibly attenuated probes.
    Cong X; Nilsen-Hamilton M
    Biochemistry; 2005 Jun; 44(22):7945-54. PubMed ID: 15924413
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Binding of short oligonucleotides to RNA: studies of the binding of common RNA structural motifs to isoenergetic microarrays.
    Kierzek E
    Biochemistry; 2009 Dec; 48(48):11344-56. PubMed ID: 19835418
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunotherapeutic utility of stimulatory and suppressive oligodeoxynucleotides.
    Ishii KJ; Gursel I; Gursel M; Klinman DM
    Curr Opin Mol Ther; 2004 Apr; 6(2):166-74. PubMed ID: 15195929
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Oligonucleotide therapeutics - an emerging novel class of compounds].
    Wacheck V
    Wien Med Wochenschr; 2006 Sep; 156(17-18):481-7. PubMed ID: 17041803
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Building oligonucleotide therapeutics using non-natural chemistries.
    Wilson C; Keefe AD
    Curr Opin Chem Biol; 2006 Dec; 10(6):607-14. PubMed ID: 17049298
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.